CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 183 enrolled
Drug / intervention
Blood Test and Report Backbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07391397
NCT07391397N/ACompleted

Reducing Rural Health Disparities by Empowering People to Minimize PFAS Exposure and Improve Cardiovascular Health

Million Marker Wellness, Inc.·interventional·Posted Feb 5, 2026·Updated May 18, 2026

In Brief

A clinical study evaluating Blood Test and Report Back for Environmental Health Effects. Completed, enrolled 183 participants across 1 site.

Detailed Summary

The goal of this observational study is to determine whether a personalized PFAS (per- and polyfluoroalkyl substances) blood test and educational report-back can improve environmental health literacy (EHL), empower exposure reduction behaviors, and promote cardiovascular wellness among rural adults. The main questions it aims to answer are: Does receiving a personalized PFAS test result and educational report-back increase environmental health literacy among rural participants and healthcare providers? Does increased EHL lead to greater readiness and actions to reduce PFAS exposure and improve wellness outcomes (e.g., reduced stress, improved sleep, increased sense of control) Researchers will compare changes from pre- to post-intervention among participants who receive the personalized PFAS report-back to see if there are measurable improvements in knowledge, behavior, and wellbeing. Participants will: Provide a mail-in blood spot sample for PFAS testing using a validated laboratory method (Relentless Health). Complete online surveys before and after receiving results to assess PFAS knowledge, exposure behaviors, and wellness outcomes. Receive a personalized PFAS report-back summarizing individual results, exposure sources, and tailored strategies for exposure reduction. Participate in focus groups or interviews (subset only) to provide feedback on report clarity, usability, and communication preferences. This study focuses on rural adult residents of Nevada, including underserved populations who may face limited access to PFAS testing or environmental health education. Insights from this Phase I project will guide a future randomized controlled trial evaluating the intervention's broader impact on cardiovascular health and rural health equity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2026
First PostedFeb 5, 2026
Enrollment StartSep 1, 2025
Primary CompletionFeb 24, 2026
Study CompletionMar 3, 2026
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 5 months ago

Interventions

Blood Test and Report Backbehavioral

Participants take an at home blood test to test their PFAS levels and receive a report back with recommendations to reduce exposures.